治疗性抗体从大脑和保留策略的退出途径
Linda Schellhammer1, Michal Beffinger1,2, Ulisse Salazar1
1Institute of Laboratory Animal Science, University of Zurich, 8952 Schlieren, Switzerland.
iScience
|November 2, 2023
概括
治疗性抗体面临着跨越血脑屏障 (BBB) 和离开大脑的挑战. 了解这些传输机制是开发神经疾病有效治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血脑屏障 (BBB) 限制了像抗体这样的大分子进入大脑,阻碍了神经系统疾病的治疗.
- 尽管有传递方法,但抗体可以被主动或被动地从中枢神经系统 (CNS) 中移除,从而限制治疗疗效.
- 了解抗体输出机制对于优化药物输送和大脑中的持续时间至关重要.
研究的目的:
- 审查当前关于中枢神经系统治疗抗体积极和被动出口的知识.
- 要突出新生儿Fc受体 (FcRn) 在活性抗体出口中的作用.
- 讨论被动流量通道的潜在贡献,并确定未来的研究方向.
主要方法:
- 对跨BBB和CNS输出抗体运输研究的文献综述.
- 分析参与受体介导细胞转移和直接输送的机制.
- 讨论实验方法来研究抗体流失通路.
主要成果:
- 治疗性抗体利用各种策略来穿越或绕过BBB.
- 活跃的出口机制,特别是涉及新生儿Fc受体 (FcRn),在从中枢神经系统中去除抗体方面发挥着重要作用.
- 包括淋巴和周血管排水在内的被动排水通道也可能导致抗体的退出.
结论:
- 将抗体治疗药物有效地输送到大脑需要考虑进入和退出机制.
- 针对FcRn介导出口可能会增强抗体在中枢神经系统中的保留.
- 对外流通路径的进一步研究将为下一代抗体治疗大脑疾病的设计提供信息.
相关概念视频
The Blood-brain Barrier
47.4K
Overview
47.4K
ER Retrieval Pathway
3.8K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.8K
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Drug Excretion: Miscellaneous Routes
68
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
68
Drug Distribution: Tissue Binding
2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.7K


